A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Breast Cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-01-05
著者
-
Kimura Tsunehito
Department Of Surgery Ii Tokyo Women's Medical University School Of Medicine
-
Kimura Tsunehito
Department Of Surgery 2 Tokyo Women's Medical University Hospital
-
TOI Masakazu
Department of Surgery Tokyo Metropolitan Komagome Hospital
-
Toi Masakazu
Department Of Breast Surgery Graduate School Of Faculty Of Medicine Kyoto University
-
Saeki Toshiaki
Department Of Breast Oncology Saitama Medical University International Medical Center
-
TAGUCHI Tetsuo
Japan Society for Cancer Chemotherapy
-
Saeki Toshiaki
Department Of Breast Oncology Saitama International Medical Center Saitama Medical University
-
Saeki Toshiaki
Department Of Clinical Research And Surgery National Hospital Organization Shikoku Cancer Center (cu
-
Saeki Toshiaki
Department Of Breast Oncology International Medical Center Saitama Medical University
関連論文
- Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer
- Evaluation of circulating tumor cells in patients with breast cancer : multi-institutional clinical trial in Japan
- Early breast cancer
- Current Status of Antibody Therapy for Breast Cancer
- Clinical Impact of Assay of Estrogen Receptor βcx in Breast Cancer
- Weekly Schedule of Docetaxel in Breast Cancer: Evaluation of Response and Toxicity
- Aromatase and Aromatase Inhibitors
- The Predictive Value of Angiogenesis for Adjuvant Therapy in Breast Cancer
- Overexpression of MDM2 in MCF-7 Promotes Both Growth Advantage and p53 Accumulation in Response to Estradiol
- Adenoid basal carcinoma of the uterine cervix : Report of two cases with reference to adenosquamous carcinoma
- Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer
- No increase of breast cancer incidence in Japanese women who received hormone replacement therapy : overview of a case-control study of breast cancer risk in Japan
- Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers
- S-1 (TS-1) maintained complete response for approximately 10 years in a case of metastatic breast cancer
- Non-Palpable Ductal Carcinoma in situ (DCIS) with Microinvasion Arising in a Radial Scar Presenting with Spiculation Alone on Mammograms : A Case Report
- Synchronous Liver Metastases of Intracystic Papillary Carcinoma with Invasion of the Breast
- Progressive Central Nervous System Metastases in Responder Patients for Outside Central Nervous System Metastases on Trastuzumab-Based Therapy : Report of Two Cases of Refractory Breast Cancer
- Occult Breast Carcinoma Presenting with Axillary Lymph Node Metastases : Follow-up of Eleven Patients
- Breast-Conserving Sungery Following Preoperative Radiotherapy to the Primary Breast Cancer of 3 cm or of the Tumors by Radiotherapy
- Proliferation of Osteoclast-Like Giant Cells in a Metastatic Bone Tumor from Stomach Cancer : Report of a Case and Analysis of the Autopsy Findings
- Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine : a case report
- What Is the Japanese Consensus on Adjuvant Chemotherapy in Breast Cancer?
- CD47 modulates OVA-specific lymphocyte proliferation and Th1/Th2 expression in children allergic to hen eggs
- Interleukin-13 Production by Peripheral Blood Mononuclear Cells from Pediatric Asthma Patients and its Modulation by Regulatory Cytokines
- Copper-transporting P-Type Adenosine Triphosphatase (ATP7B) Is Expressed in Human Breast Carcinoma
- Phase I Study of Docetaxel and Cyclophosphamide in Patients with Advanced or Recurrent Breast Cancer
- A Phase II Study of S-1 in Patients with Metastatic Breast Cancer : A Japanese Trial by the S-1 Cooperative Study Group, Breast Cancer Working Group
- Evaluation of HER2 Status: For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab) (Pathological Committee for Optimal Use of Trastuzumab)
- Localization of Estrone Sulfatase in Human Breast Carcinomas
- A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Breast Cancer
- Outcome of Breast-Conserving Therapy in the Tokyo Women's Medical University Breast Cancer Society Experience
- New Prognostic Factors Associated with Long-term Survival in Node-Negative Breast Cancer Patients
- Clinicopathologic Features Associated with Long-Term Survival in Node-Negative Breast Cancer Patients
- Phase I studies of nogitecan hydrochloride for Japanese
- Prognostic Factors for Node-Negative Breast Cancers: Results of a Study Program by the Japanese Breast Cancer Society
- Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma
- MDM2 in Breast Cancer
- Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
- Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology
- From standardization to personalization in breast cancer treatment
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Efficacy and Toxicity of Vinorelbine with Doxorubicin/Cyclophosphamide Combination Chemotherapy in a Phase I-II Study for Advanced or Recurrent Breast Cancer Patients
- Radiotherapy with Concurrent Docetaxel for Advanced and Recurrent Breast Cancer
- Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer : Association with progression and prognosis
- Expression of Multidrug Resistance-related Transporters in Human Breast Carcinoma
- BiClamp Forceps Significantly Shorten the Operation Time for Breast Surgery
- Molecular target therapy : basics and clinical application
- Dissociation of Bax from a Bcl-2/Bax Heterodimer Triggered by Phosphorylation of Serine 70 of Bcl-2
- The Clinical Utility of Docetaxel in Adriamycin-Resistant Breast Cancer
- Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach
- Novel Sensitizing Agents : Potential Contribution of COX-2 Inhibitor for Endocrine Therapy of Breast Cancer
- Chemoendocrine Therapy: Basic Science and Clinical Aspects
- ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA : MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS
- Angiosarcoma of the Breast: Report of a Case and Autopsy Findings
- Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast
- Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast : A Dilemma
- Plasma Nucleosome Levels in Node-Negative Breast Cancer Patients
- Interleukin-4 and Breast Cancer
- Capecitabine plus Docetaxel Combination Chemotherapy for Metastatic Breast Cancer
- Update of evidence in chemotherapy for breast cancer
- Who Benefits from Hormone Therapy?
- Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
- Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats
- A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy
- Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer
- Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients
- Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer : a pilot study
- Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer : novel marker genes and prediction model using the expression levels
- ^F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response
- Breast MR Image Fusion by Deformable Implicit Polynomial (DIP)
- Breast MR Image Fusion by Deformable Implicit Polynomial (DIP)
- Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer : additional safety analysis of a phase II study